Cargando…

Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting

Detalles Bibliográficos
Autores principales: Bonora, S, Calcagno, A, Viganò, O, Bigliano, P, Rusconi, S, Trentini, L, Tettoni, MC, Orofino, G, Salassa, B, Bramato, C, D'Avolio, A, Siccardi, M, Colella, E, Galli, M, Di Perri, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113051/
http://dx.doi.org/10.1186/1758-2652-13-S4-P48
_version_ 1782205876867694592
author Bonora, S
Calcagno, A
Viganò, O
Bigliano, P
Rusconi, S
Trentini, L
Tettoni, MC
Orofino, G
Salassa, B
Bramato, C
D'Avolio, A
Siccardi, M
Colella, E
Galli, M
Di Perri, G
author_facet Bonora, S
Calcagno, A
Viganò, O
Bigliano, P
Rusconi, S
Trentini, L
Tettoni, MC
Orofino, G
Salassa, B
Bramato, C
D'Avolio, A
Siccardi, M
Colella, E
Galli, M
Di Perri, G
author_sort Bonora, S
collection PubMed
description
format Online
Article
Text
id pubmed-3113051
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130512011-06-13 Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting Bonora, S Calcagno, A Viganò, O Bigliano, P Rusconi, S Trentini, L Tettoni, MC Orofino, G Salassa, B Bramato, C D'Avolio, A Siccardi, M Colella, E Galli, M Di Perri, G J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113051/ http://dx.doi.org/10.1186/1758-2652-13-S4-P48 Text en Copyright ©2010 Bonora et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Bonora, S
Calcagno, A
Viganò, O
Bigliano, P
Rusconi, S
Trentini, L
Tettoni, MC
Orofino, G
Salassa, B
Bramato, C
D'Avolio, A
Siccardi, M
Colella, E
Galli, M
Di Perri, G
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
title Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
title_full Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
title_fullStr Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
title_full_unstemmed Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
title_short Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
title_sort analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113051/
http://dx.doi.org/10.1186/1758-2652-13-S4-P48
work_keys_str_mv AT bonoras analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT calcagnoa analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT viganoo analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT biglianop analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT rusconis analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT trentinil analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT tettonimc analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT orofinog analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT salassab analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT bramatoc analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT davolioa analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT siccardim analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT colellae analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT gallim analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting
AT diperrig analysisofdeterminantsoflongtermefficacyofunboostedatazanavirbasedregimensintheclinicalsetting